| FLNA |
FLNA, FLN, FLN1: Filamin-A |
ARHGDIB |
ARHGDIB, GDIA2, GDID4, RAP1GN1: Rho GDP-dissociation inhibitor 2 |
6.407 |
Evidence |
|
| TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
ADAM17 |
ADAM17, CSVP, TACE: ADAM 17 precursor |
6.407 |
Evidence |
|
| RXRA |
RXRA, NR2B1: Retinoic acid receptor RXR-alpha |
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
6.407 |
Evidence |
|
| LAMP1 |
LAMP1: Lysosome-associated membrane glycoprotein 1 precursor |
LAMP2 |
LAMP2: Lysosome-associated membrane glycoprotein 2 precursor |
6.407 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
6.407 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
DNM2 |
IPI00218889 |
6.407 |
Evidence |
|
| SPARC |
SPARC, ON: SPARC precursor |
BGN |
BGN: Biglycan precursor |
6.407 |
Evidence |
|
| CXCL1 |
CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor |
IL8 |
IL8: Interleukin-8 precursor |
6.407 |
Evidence |
|
| CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
6.407 |
Evidence |
|
| NR3C1 |
NR3C1, GRL: Glucocorticoid receptor |
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
6.407 |
Evidence |
|
| APOA1 |
APOA1: Apolipoprotein A-I precursor |
PCOLCE |
PCOLCE, PCPE1: Procollagen C-endopeptidase enhancer 1 precursor |
6.407 |
Evidence |
|
| A2M |
A2M, FWP007: Alpha-2-macroglobulin precursor |
ALB |
ALB: Uncharacterized protein ALB |
6.407 |
Evidence |
|
| AGT |
AGT, SERPINA8: Angiotensinogen precursor |
SERPINA3 |
IPI00550991 |
6.407 |
Evidence |
|
| SERPINA1 |
SERPINA1, AAT, PRO0684, PI, PRO2209: Alpha-1-antitrypsin precursor |
SERPINA3 |
IPI00550991 |
6.407 |
Evidence |
|
| AURKA |
AURKA, AIK, ARK1, AURA, BTAK, STK15, STK6: Serine/threonine-protein kinase 6 |
BAZ1B |
BAZ1B, WBSC10, WBSCR10, WBSCR9, WSTF: Bromodomain adjacent to zinc finger domain |
6.407 |
Evidence |
|
| SLC9A3R1 |
SLC9A3R1, NHERF: Ezrin-radixin-moesin-binding phosphoprotein 50 |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
6.407 |
Evidence |
|
| SLC9A3R1 |
SLC9A3R1, NHERF: Ezrin-radixin-moesin-binding phosphoprotein 50 |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
6.407 |
Evidence |
|
| SLC9A3R1 |
SLC9A3R1, NHERF: Ezrin-radixin-moesin-binding phosphoprotein 50 |
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
6.407 |
Evidence |
|
| SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
PLAU |
Plasminogen activator, urokinase |
6.405 |
Evidence |
|
| MPP6 |
MPP6, VAM1: MAGUK p55 subfamily member 6 |
CFL2 |
CFL2: Cofilin-2 |
6.405 |
Evidence |
|
| TMSL8 |
TMSL8, TMSNB: NB thymosin beta |
CFL2 |
CFL2: Cofilin-2 |
6.405 |
Evidence |
|
| MAPKAPK5 |
IPI00160672 |
CFL2 |
CFL2: Cofilin-2 |
6.405 |
Evidence |
|
| SMC1L1 |
SMC1A, DXS423E, KIAA0178, SB1.8, SMC1, SMC1L1: Structural maintenance of chromos |
MAPKAPK5 |
IPI00160672 |
6.405 |
Evidence |
|
| EIF2B5 |
EIF2B5, EIF2BE: Translation initiation factor eIF-2B subunit epsilon |
ATXN2L |
ATXN2L, A2D, A2LG, A2LP, A2RP: Ataxin-2-like protein |
6.405 |
Evidence |
|
| VSNL1 |
VSNL1, VISL1: Visinin-like protein 1 |
CFL2 |
CFL2: Cofilin-2 |
6.405 |
Evidence |
|